• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝纤维化过程中血管紧张素原的表达及其对肝星状细胞的影响。

Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells.

机构信息

Department of Geriatrics, 9th People's Hospital Affiliated to School of Medicine, Shanghai Jiaotong University, Shanghai, China.

出版信息

Med Sci Monit. 2011 Sep;17(9):BR248-56. doi: 10.12659/msm.881928.

DOI:10.12659/msm.881928
PMID:21873937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3560510/
Abstract

BACKGROUND

The liver renin-angiotensin system (RAS) plays an important role in promoting the development of hepatic fibrogenesis. Angiotensinogen (AGT) is an important precursor in tissue RAS. This study aimed to investigate the expression and cellular source of AGT in hepatic fibrogenesis and its effect on proliferation and collagen metabolism of hepatic stellate cells.

MATERIAL/METHODS: In a rat carbon tetrachloride (CCl4)-induced liver fibrosis model the mRNA expression of AGT was determined by real-time PCR and the cellular source of AGT was determined by immunohistochemical staining. In vitro HSC-T6 cells were transfected with AGT, and the expression plasmid, AGT shRNA plasmid and negative shRNA plasmid were constructed. Real-time PCR and ELISA were applied to determine the mRNA expressions and contents of TIMP-1, TGF-β1, type I collagen and type III collagen of the cells or in the supernatants.

RESULTS

Compared to normal liver, the AGT and α-SMA mRNA expressions increased at the early stage of hepatic fibrosis and decreased in hepatic cirrhosis. The expressions of AGT and α-SMA mRNA were correlated with the hepatic fibrosis (r=0.915, P=0.03). Immunohistochemistry demonstrated the activated HSCs were the main source of AGT due to colocalization of AGT and α-SMA expressions. The mRNA and protein of TGF-β1, TIMP-1, type I collagen and type III collagen were markedly up-regulated.

CONCLUSIONS

ACEI and angiotensin II type 1 receptor antagonist (AT1RA) could attenuate the progression of hepatic fibrosis in the early stage. Direct inhibition of AGT from aHSCs may become an effective antifibrotic anti-liver fibrosis strategy.

摘要

背景

肝脏肾素-血管紧张素系统(RAS)在促进肝纤维化发展中起重要作用。血管紧张素原(AGT)是组织 RAS 的重要前体。本研究旨在探讨肝纤维化过程中 AGT 的表达和细胞来源及其对肝星状细胞增殖和胶原代谢的影响。

材料/方法:采用四氯化碳(CCl4)诱导大鼠肝纤维化模型,实时 PCR 检测 AGT 的 mRNA 表达,免疫组化染色检测 AGT 的细胞来源。体外 HSC-T6 细胞转染 AGT,构建 AGT 表达质粒、AGT shRNA 质粒和阴性 shRNA 质粒。实时 PCR 和 ELISA 检测细胞或上清液中 TIMP-1、TGF-β1、I 型胶原和 III 型胶原的 mRNA 表达和含量。

结果

与正常肝组织相比,肝纤维化早期 AGT 和 α-SMA 的 mRNA 表达增加,肝硬化时降低。AGT 和 α-SMA mRNA 的表达与肝纤维化相关(r=0.915,P=0.03)。免疫组化显示,活化的 HSCs 是 AGT 的主要来源,因为 AGT 与 α-SMA 的表达存在共定位。TGF-β1、TIMP-1、I 型胶原和 III 型胶原的 mRNA 和蛋白表达明显上调。

结论

ACEI 和血管紧张素 II 型 1 受体拮抗剂(AT1RA)可抑制肝纤维化早期进展。直接抑制活化的 HSCs 中的 AGT 可能成为一种有效的抗肝纤维化策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/d861ce8b2500/medscimonit-17-9-BR248-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/5d20c6f5385e/medscimonit-17-9-BR248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/56486d27ff46/medscimonit-17-9-BR248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/100db54bc580/medscimonit-17-9-BR248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/118690648e78/medscimonit-17-9-BR248-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/5b0252abc583/medscimonit-17-9-BR248-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/c6a3b263f574/medscimonit-17-9-BR248-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/85b8e9225f55/medscimonit-17-9-BR248-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/f622966c5acf/medscimonit-17-9-BR248-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/d861ce8b2500/medscimonit-17-9-BR248-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/5d20c6f5385e/medscimonit-17-9-BR248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/56486d27ff46/medscimonit-17-9-BR248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/100db54bc580/medscimonit-17-9-BR248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/118690648e78/medscimonit-17-9-BR248-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/5b0252abc583/medscimonit-17-9-BR248-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/c6a3b263f574/medscimonit-17-9-BR248-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/85b8e9225f55/medscimonit-17-9-BR248-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/f622966c5acf/medscimonit-17-9-BR248-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1390/3560510/d861ce8b2500/medscimonit-17-9-BR248-g009.jpg

相似文献

1
Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells.肝纤维化过程中血管紧张素原的表达及其对肝星状细胞的影响。
Med Sci Monit. 2011 Sep;17(9):BR248-56. doi: 10.12659/msm.881928.
2
Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.小干扰RNA对大鼠肝星状细胞中纤溶酶原激活物抑制剂-1表达的抑制作用
J Gastroenterol Hepatol. 2008 Dec;23(12):1917-25. doi: 10.1111/j.1440-1746.2008.05485.x. Epub 2008 Aug 28.
3
K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.钾离子通道抑制可降低纤维化大鼠的门静脉灌注压以及肝星状细胞的纤维化相关特征。
Liver Int. 2015 Apr;35(4):1244-52. doi: 10.1111/liv.12681. Epub 2014 Sep 22.
4
[Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].[重组转化生长因子-β3对胶原合成与沉积的影响:大鼠肝纤维化细胞模型实验]
Zhonghua Yi Xue Za Zhi. 2008 May 13;88(18):1273-8.
5
Role of growth factor receptor-bound 2 in CCl-induced hepatic fibrosis.生长因子受体结合蛋白2在四氯化碳诱导的肝纤维化中的作用。
Biomed Pharmacother. 2017 Aug;92:942-951. doi: 10.1016/j.biopha.2017.05.142. Epub 2017 Jun 10.
6
Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.黄芪总皂苷与甘草酸通过调节TGF-β1/Smads信号通路协同发挥抗肝纤维化作用。
J Ethnopharmacol. 2016 Aug 22;190:83-90. doi: 10.1016/j.jep.2016.06.011. Epub 2016 Jun 6.
7
Resistin mediates the hepatic stellate cell phenotype.抵抗素介导肝星状细胞表型。
World J Gastroenterol. 2013 Jul 28;19(28):4475-85. doi: 10.3748/wjg.v19.i28.4475.
8
Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.氟伐他汀通过抑制肝细胞对肝星状细胞的旁分泌作用减轻大鼠肝脂肪变性诱导的纤维化。
BMC Gastroenterol. 2015 Feb 15;15:22. doi: 10.1186/s12876-015-0248-8.
9
Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl-induced hepatic fibrosis in rats in vivo.苦杏仁苷抑制 TGFβ1 在体外诱导的肝星状细胞(HSCs)活化和 CCl 在体内诱导的大鼠肝纤维化。
Int Immunopharmacol. 2021 Jan;90:107151. doi: 10.1016/j.intimp.2020.107151. Epub 2020 Dec 6.
10
Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.甘草酸抑制四氯化碳诱导的大鼠肝损伤中的细胞凋亡和纤维化。
World J Gastroenterol. 2015 May 7;21(17):5271-80. doi: 10.3748/wjg.v21.i17.5271.

引用本文的文献

1
Liver Characterization of a Cohort of Alpha-1 Antitrypsin Deficiency Patients with and without Lung Disease.一组有或无肺部疾病的α-1抗胰蛋白酶缺乏症患者的肝脏特征分析
J Clin Transl Hepatol. 2024 Oct 28;12(10):845-856. doi: 10.14218/JCTH.2024.00201. Epub 2024 Sep 14.
2
Genetic Polymorphism in Angiotensinogen and Its Association with Cardiometabolic Diseases.血管紧张素原的基因多态性及其与心血管代谢疾病的关联。
Metabolites. 2022 Dec 19;12(12):1291. doi: 10.3390/metabo12121291.
3
Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis.

本文引用的文献

1
Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.在胆管结扎大鼠模型中,血管紧张素受体阻滞剂在抑制肝纤维化方面优于血管紧张素转换酶抑制剂。
J Gastroenterol. 2008;43(11):889-96. doi: 10.1007/s00535-008-2239-9. Epub 2008 Nov 18.
2
Mechanisms of hepatic fibrogenesis.肝纤维化形成机制。
Gastroenterology. 2008 May;134(6):1655-69. doi: 10.1053/j.gastro.2008.03.003.
3
Hepatic stellate cells and liver fibrosis.肝星状细胞与肝纤维化
酒精性肝硬化中白细胞衍生趋化因子-2和成纤维细胞生长因子21
World J Hepatol. 2021 Dec 27;13(12):2071-2080. doi: 10.4254/wjh.v13.i12.2071.
4
Proteomic analysis of serum samples of paracoccidioidomycosis patients with severe pulmonary sequel.对患有严重肺部后遗症的副球孢子菌病患者血清样本进行蛋白质组学分析。
PLoS Negl Trop Dis. 2021 Aug 23;15(8):e0009714. doi: 10.1371/journal.pntd.0009714. eCollection 2021 Aug.
5
Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway.卡维地洛通过 RhoA/Rho 激酶通路抑制肝星状细胞中血管紧张素 II 诱导的增殖和收缩。
Biomed Res Int. 2019 Nov 7;2019:7932046. doi: 10.1155/2019/7932046. eCollection 2019.
6
Balancing Effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R Axis and ACE2-Ang-(1-7)-Mas Axis in Rats with CCl-Induced Hepatic Fibrosis.鳖甲煎口服液对 CCl4 诱导肝纤维化大鼠 ACE-AngⅡ-AT1R 轴和 ACE2-Ang-(1-7)-Mas 轴的平衡作用。
Chin J Integr Med. 2018 Nov;24(11):853-859. doi: 10.1007/s11655-017-2909-7. Epub 2018 Jan 15.
7
Exploring multiple quantitative trait loci models of hepatic fibrosis in a mouse intercross.在小鼠杂交中探索肝纤维化的多个数量性状基因座模型。
Mamm Genome. 2016 Feb;27(1-2):70-80. doi: 10.1007/s00335-015-9609-4. Epub 2015 Nov 7.
8
MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1.微小RNA-34a通过靶向ACSL1促进肝星状细胞激活。
Med Sci Monit. 2015 Oct 6;21:3008-15. doi: 10.12659/MSM.894000.
9
The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease.BARD 评分和 NAFLD 纤维化评分在非酒精性脂肪性肝病中评估进展性肝纤维化的价值。
Med Sci Monit. 2012 Dec;18(12):CR735-40. doi: 10.12659/msm.883601.
10
Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis.Smad7 和 UPA 的共表达可减轻四氯化碳诱导的大鼠肝纤维化。
Med Sci Monit. 2012 Oct;18(10):BR394-401. doi: 10.12659/msm.883479.
Arch Pathol Lab Med. 2007 Nov;131(11):1728-34. doi: 10.5858/2007-131-1728-HSCALF.
4
Significance of chymase-dependent angiotensin II formation in the progression of human liver fibrosis.糜酶依赖性血管紧张素 II 形成在人类肝纤维化进展中的意义。
Hepatol Res. 2008 May;38(5):501-10. doi: 10.1111/j.1872-034X.2007.00271.x. Epub 2007 Oct 1.
5
Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.抑制肾素-血管紧张素系统可减轻大鼠肝纤维化和氧化应激的发展。
Clin Exp Pharmacol Physiol. 2008 Feb;35(2):159-67. doi: 10.1111/j.1440-1681.2007.04797.x. Epub 2007 Sep 27.
6
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis.血管紧张素II 1型受体阻滞剂抑制大鼠非酒精性脂肪性肝炎中的纤维化。
Hepatology. 2007 Jun;45(6):1375-81. doi: 10.1002/hep.21638.
7
Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.酒精性肝炎患者候选基因的肝脏表达:与疾病严重程度的相关性。
Gastroenterology. 2007 Feb;132(2):687-97. doi: 10.1053/j.gastro.2006.12.036. Epub 2006 Dec 20.
8
Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis.血管紧张素II受体拮抗剂对非酒精性脂肪性肝炎中肝星状细胞激活的抑制作用。
World J Gastroenterol. 2006 Jan 14;12(2):322-6. doi: 10.3748/wjg.v12.i2.322.
9
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.疾病机制:肝纤维化的机制及治疗意义
Nat Clin Pract Gastroenterol Hepatol. 2004 Dec;1(2):98-105. doi: 10.1038/ncpgasthep0055.
10
Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension.血管紧张素 II 型 1 型受体在人肝硬化肝脏中的表达:与纤维化和门脉高压的关系。
Hepatol Res. 2005 Jun;32(2):107-16. doi: 10.1016/j.hepres.2005.01.017.